Member Authors
Digital Access
50+ Titles

AHLA Legal Issues in Health Care Fraud and Abuse (Non-Members)

​Now includes the 2023 Cumulative Supplement to the Fifth Edition, prepared in response to the latest and most significant developments in what the government considers to constitute "fraud" or "abuse."

Publisher: AHLA

Select a format

Print Book:1 volume, Softbound, 898 pages
5th Edition with 2023 Cumulative Supplement
ISBN/ISSN: 9780769881584
In Stock
Price
$265.00
QTY
eBook:epub
5th Edition with 2023 Cumulative Supplement
ISBN/ISSN: 9780769881607
In Stock
Price
$260.00
Best value
QTY
eBook:mobi
5th Edition with 2023 Cumulative Supplement
ISBN/ISSN: 9780769881607
In Stock
Price
$260.00
Best value
QTY
International Order Inquiry

Product description

View a sample of this title using the ReadNow feature

Since the Fifth Edition of Legal Issues in Health Care Fraud and Abuse was published in 2020, the government has continued to provide further regulation and guidance in the fraud and abuse context, while also continuing to actively enforce health care fraud and abuse laws.

This resource has been updated to include information on those recent activities:

  • Federal agencies have continued to aggressively pursue both individuals and entities for potential violations of fraud and abuse laws, including in connection with COVID-19.
  • The DOJ has been active in pursuing health care providers and life sciences manufacturers for violations of the civil False Claims Act in cases involving a wide variety of conduct.
  • Whistleblowers have been active in bringing cases and, increasingly, pursuing those in which the government declines to intervene.
  • The Office of Inspector General for the Department of Health and Human Services (HHS-OIG) and the Centers for Medicare & Medicaid Services finalized additions and revisions to regulations under the Anti-Kickback Statute and Physician Self-Referral Law (also known as the Stark Law).
  • The HHS-OIG issued two Special Fraud Alerts, expressing skepticism regarding in-person "speaker programs," and warning health care practitioners of the risks of entering into arrangements with "purported telemedicine companies."
  • The HHS-OIG issued numerous advisory opinions to a range of entities, including hospitals, pharmaceutical manufacturers, device manufacturers, and others.
  • And much more

These changes and their anticipated impacts are examined in the 2023 Cumulative Supplement to Legal Issues in Health Care Fraud and Abuse, a foundational resource now updated to address recent shifts in the government's approach to regulation and enforcement of health care fraud and abuse.

eBooks, CDs, downloadable content, and software purchases are noncancelable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® service for further legal research options. A valid subscription to Lexis+ is required to access this content.

The 4th Edition ISBN was 9780769881584.

Published September, 2020, with August 2023 Cumulative Supplement.

 

Featured Authors

Table of contents

 1  The Fraud Enforcers: Who Are They and What Do They Do? 

2  Federal Anti-Kickback Laws

3  Federal Physician Self-Referral Prohibitions

4  Administrative Sanctions Available to Federal Enforcers

5  The False Claims Act and Other Means of Federal Enforcement of Health Care Fraud
    and Abuse Laws

6  State and Private Initiatives to Combat Fraud

7  Compliance and Self-Reporting